1
|
Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part II. Coord Chem Rev 2023. [DOI: 10.1016/j.ccr.2022.214899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
2
|
Abstract
Platinum-based anticancer drugs are most likely the most successful group of bioinorganic compounds. Their apparent disadvantages have led to the development of anticancer compounds of other noble metals, resulting in several ruthenium-based drugs which have entered clinical trials on oncological patients. Besides ruthenium, numerous rhodium complexes have been recently reported as highly potent antiproliferative agents against various human cancer cells, making them potential alternatives to Pt- and Ru-based metallodrugs. In this review, half-sandwich Rh(III) complexes are overviewed. Many representatives show higher in vitro potency than and different mechanisms of action (MoA) from the conventional anticancer metallodrugs (cisplatin in most cases) or clinically studied Ru drug candidates. Furthermore, some of the reviewed Rh(III) arenyl complexes are also anticancer in vivo. Pioneer anticancer organorhodium compounds as well as the recent advances in the field are discussed properly, and adequate attention is paid to their anticancer activity, solution behaviour and various processes connected with their MoA. In summary, this work summarizes the types of compounds and the most important biological results obtained in the field of anticancer half-sandwich Rh complexes.
Collapse
|
3
|
Hassoon AA, Szorcsik A, Bogár F, Papp IZ, Fülöp L, Kele Z, Gajda T. The interaction of half-sandwich (η 5-Cp*)Rh(III) cation with histidine containing peptides and their ternary species with (N,N) bidentate ligands. J Inorg Biochem 2020; 216:111330. [PMID: 33360738 DOI: 10.1016/j.jinorgbio.2020.111330] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Revised: 11/23/2020] [Accepted: 12/01/2020] [Indexed: 12/28/2022]
Abstract
Our goal was to explore the possible interactions of the potential metallodrug (η5-Cp*)Rh(III) complexes with histidine containing biomolecules (peptides/proteins) in order to understand the most important thermodynamic factors influencing the biospeciation and biotransformation of (η5-Cp*)Rh(III) complexes. To this end, here we report systematic solution thermodynamic and solution structural study on the interaction of (η5-Cp*)Rh(III) cation with histidine containing peptides and their constituents ((N-methyl)imidazole, GGA-OH, GGH-OH, histidine-amide, HGG-OH, GHG-NH2), based on extensive 1H NMR, ESI-MS and potentiometric investigations. The comparative evaluation of our data indicated that (η5-Cp*)Rh(III) cation is able to induce the deprotonation of amide nitrogen well below pH 7. Consequently, at physiological pH the peptides are coordinated to Rh(III) by tridentate manner, with the participation of amide nitrogen. At pH 7.4 the (η5-Cp*)Rh(III) binding affinity of peptides follow the order GGA-OH < < GGH-OH < < histidine-amide < HGG-OH < GHG-NH2, i.e. the observed binding strength essentially depends on the presence and position of histidine within the peptide sequence. We also performed computational study on the possible solution structures of complexes present at near physiological pH. At pH 7.4 all histidine containing peptides form ternary complexes with strongly coordinating (N,N) bidentate ligands (ethylenediamine or bipyridyl), in which the peptides are monodentately coordinated to Rh(III) through their imidazole N1‑nitrogens. In addition, the strongest chelators histidine-amide, HGG-OH and GHG-NH2 are also able to displace these powerful bidentate ligands from the coordination sphere of Rh(III).
Collapse
Affiliation(s)
- Azza A Hassoon
- Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary
| | - Attila Szorcsik
- Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary
| | - Ferenc Bogár
- Institute of Medical Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary; MTA-SZTE Biomimetic Systems Research Group, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary
| | - Ibolya Zita Papp
- Institute of Medical Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary
| | - Lívia Fülöp
- Institute of Medical Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary
| | - Zoltán Kele
- Institute of Medical Chemistry, University of Szeged, Dóm tér 8, H-6720 Szeged, Hungary
| | - Tamás Gajda
- Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary.
| |
Collapse
|
4
|
Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes. Bioorg Chem 2020; 105:104396. [PMID: 33130345 DOI: 10.1016/j.bioorg.2020.104396] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 10/16/2020] [Accepted: 10/18/2020] [Indexed: 12/22/2022]
Abstract
Metal-based inhibitors of histone deacetylases (HDAC), DNA topoisomerases (Topos) and Epidermal Growth Factor Receptor (EGFR) have demonstrated their cytotoxic potential against various cancer types such as breast, lung, uterus, colon, etc. Additionally, these have proven their role in resolving the resistance issues, enhancing the affinity, lipophilicity, stability, and biocompatibility and therefore, emerged as potential candidates for molecularly targeted therapeutics. This review focusses on nature and role of metals and organic ligands in tuning the anticancer activity in multiple modes of inhibition considering HDACs, Topos or EGFR as one of the primary targets. The conceptual design and synthetic approaches of platinum and non-platinum metal complexes comprising of chiefly ruthenium, rhodium, palladium, copper, iron, nickel, cobalt, zinc metals coordinated with organic scaffolds, along with their biological activity profiles, structure-activity relationships (SARs), docking studies, possible modes of action, and their scope and limitations are discussed in detail.
Collapse
|
5
|
Liu JH, Pan FH, Wang ZF, Wang R, Yang L, Qin QP, Tan MX. Synthesis, crystal structure and biological evaluation of three new Rh(III) complexes incorporating benzimidazole derivatives. INORG CHEM COMMUN 2020. [DOI: 10.1016/j.inoche.2020.108017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
6
|
Nagy I, Farkas E, Kasparkova J, Kostrhunova H, Brabec V, Buglyó P. Synthesis and characterization of (Ru(II), Co(III)) heterobimetallic complexes formed with a 1,10-phenanthroline based hydroxamic acid conjugate. J Organomet Chem 2020. [DOI: 10.1016/j.jorganchem.2020.121265] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
Anticancer Ruthenium Complexes with HDAC Isoform Selectivity. Molecules 2020; 25:molecules25102383. [PMID: 32455529 PMCID: PMC7287671 DOI: 10.3390/molecules25102383] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 05/13/2020] [Accepted: 05/16/2020] [Indexed: 01/08/2023] Open
Abstract
The histone deacetylase (HDAC) enzymes have emerged as an important class of molecular targets in cancer therapy, with five inhibitors in clinical use. Recently, it has been shown that a lack of selectivity between the 11 Zn-dependent HDAC isoforms may lead to unwanted side-effects. In this paper, we show that piano stool Ru complexes can act as HDAC inhibitors, and variation in the capping arene leads to differences in HDAC isoform selectivity.
Collapse
|
8
|
Ye R, Tan C, Chen B, Li R, Mao Z. Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents. Front Chem 2020; 8:402. [PMID: 32509730 PMCID: PMC7248183 DOI: 10.3389/fchem.2020.00402] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Accepted: 04/16/2020] [Indexed: 01/13/2023] Open
Abstract
DNA is considered to be the primary target of platinum-based anticancer drugs which have gained great success in clinics, but DNA-targeted anticancer drugs cause serious side-effects and easily acquired drug resistance. This has stimulated the search for novel therapeutic targets. In the past few years, substantial research has demonstrated that zinc-containing metalloenzymes play a vital role in the occurrence and development of cancer, and they have been identified as alternative targets for metal-based anticancer agents. Metal complexes themselves have also exhibited a lot of appealing features for enzyme inhibition, such as: (i) the facile construction of 3D structures that can increase the enzyme-binding selectivity and affinity; (ii) the intriguing photophysical and photochemical properties, and redox activities of metal complexes can offer possibilities to design enzyme inhibitors with multiple modes of action. In this review, we discuss recent examples of zinc-containing metalloenzyme inhibition of metal-based anticancer agents, especially three zinc-containing metalloenzymes overexpressed in tumors, including histone deacetylases (HDACs), carbonic anhydrases (CAs), and matrix metalloproteinases (MMPs).
Collapse
Affiliation(s)
- Ruirong Ye
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China.,MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-sen University, Guangzhou, China
| | - Caiping Tan
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-sen University, Guangzhou, China
| | - Bichun Chen
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China
| | - Rongtao Li
- Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China
| | - Zongwan Mao
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-sen University, Guangzhou, China
| |
Collapse
|
9
|
Damercheli M, Mahdi M, Mehravi B, Shafiee Ardestani M. Bioactive Salen-type Schiff Base Transition Metal Complexes as Possible Anticancer Agents. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH : IJPR 2020; 18:2055-2066. [PMID: 32184869 PMCID: PMC7059031 DOI: 10.22037/ijpr.2019.12792.11151] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Although metal-based anticancer drugs have been recognized as the most effective agents over the organic compounds, non-selectivity and high toxic effects have limited their applications in a way that only three Pt-analogues have progressed into clinical use. These problems have spurred chemists to develop different strategies based on alternative targets. This work focuses on predicting potency and mode of interactions of a series of salen type Schiff base transition metal complexes derived from meso-1,2-diphenyl-1,2-ethylenediamine, over some proteins (HDAC7, HDAC2, CatB, B-RAF kinase, TopII, RNR, TS, and rHA) using computational docking method, to be later considered as possible anticancer agents. The obtained results showed that all complexes exhibited higher affinity for HDAC7 than the other targets. Moreover, the bromo-derivatives of the copper compounds were more active on HDAC7 than the other derivatives. Such bromo compounds showed considerable interactions with Kinase, RNR, TS, and CatB. Contrary to Histone deacetylase (HAD)C7; HDAC2 was predicted to be relatively poor target. As expected, formation of the hydrophobic interactions between the metal complexes and the protein targets were essential for activity of the metal compounds. This study provides some more information for further optimizations and development of new metallodrugs as enzyme inhibitors for potential therapeutic agents.
Collapse
Affiliation(s)
- Maryam Damercheli
- Department of Inorganic Chemistry, Faculty of Chemistry, Semnan University, Semnan, Iran
| | - Mahdi Mahdi
- Department of Inorganic Chemistry, Faculty of Chemistry, Semnan University, Semnan, Iran
| | - Bita Mehravi
- Department of Medical Nanotechnology, Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - Mehdi Shafiee Ardestani
- Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
10
|
Walton JW, Cross JM, Riedel T, Dyson PJ. Perfluorinated HDAC inhibitors as selective anticancer agents. Org Biomol Chem 2018; 15:9186-9190. [PMID: 29072756 DOI: 10.1039/c7ob02339a] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
A series of potent histone deacetylase inhibitors is presented that incorporate alkyl or perfluorinated alkyl chains. Several new compounds show greater in vitro antiproliferative activity than the clinically approved inhibitor, SAHA. Furthermore, the new compounds show up to 5-fold greater activity against cancer cells than healthy cells. This selectivity is in contrast to SAHA, which is more active against the healthy cell line than the cancer cell line tested. Finally, we report an increase in activity for SAHA under mild hyperthermia, indicating that it could be an interesting candidate to use in combination with thermal therapy.
Collapse
Affiliation(s)
- James W Walton
- Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, UK.
| | | | | | | |
Collapse
|
11
|
Štarha P, Trávníček Z, Drahoš B, Herchel R, Dvořák Z. Cell-based studies of the first-in-class half-sandwich Ir(III) complex containing histone deacetylase inhibitor 4-phenylbutyrate. Appl Organomet Chem 2018. [DOI: 10.1002/aoc.4246] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Pavel Štarha
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science; Palacký University in Olomouc; 17. listopadu 12 771 46 Olomouc Czech Republic
| | - Zdeněk Trávníček
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science; Palacký University in Olomouc; 17. listopadu 12 771 46 Olomouc Czech Republic
| | - Bohuslav Drahoš
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science; Palacký University in Olomouc; 17. listopadu 12 771 46 Olomouc Czech Republic
| | - Radovan Herchel
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials, Faculty of Science; Palacký University in Olomouc; 17. listopadu 12 771 46 Olomouc Czech Republic
| | - Zdeněk Dvořák
- Department of Cell Biology and Genetics & Regional Centre of Advanced Technologies and Materials, Faculty of Science; Palacký University in Olomouc; Šlechtitelů 27 783 71 Olomouc Czech Republic
| |
Collapse
|
12
|
Mészáros JP, Dömötör O, Hackl CM, Roller A, Keppler BK, Kandioller W, Enyedy ÉA. Structural and solution equilibrium studies on half-sandwich organorhodium complexes of (N,N) donor bidentate ligands. NEW J CHEM 2018. [DOI: 10.1039/c8nj01681j] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Characterization, solution stability, chloride affinity and crystal structures of [Rh(η5-C5Me5)(N^N)(H2O)]2+ complexes and their correlation analysis.
Collapse
Affiliation(s)
- János P. Mészáros
- Department of Inorganic and Analytical Chemistry
- University of Szeged
- H-6720 Szeged
- Hungary
| | - Orsolya Dömötör
- Department of Inorganic and Analytical Chemistry
- University of Szeged
- H-6720 Szeged
- Hungary
| | - Carmen M. Hackl
- Institute of Inorganic Chemistry
- Faculty of Chemistry
- University of Vienna
- A-1090 Vienna
- Austria
| | - Alexander Roller
- Institute of Inorganic Chemistry
- Faculty of Chemistry
- University of Vienna
- A-1090 Vienna
- Austria
| | - Bernhard K. Keppler
- Institute of Inorganic Chemistry
- Faculty of Chemistry
- University of Vienna
- A-1090 Vienna
- Austria
| | - Wolfgang Kandioller
- Institute of Inorganic Chemistry
- Faculty of Chemistry
- University of Vienna
- A-1090 Vienna
- Austria
| | - Éva A. Enyedy
- Department of Inorganic and Analytical Chemistry
- University of Szeged
- H-6720 Szeged
- Hungary
| |
Collapse
|
13
|
Štarha P, Trávníček Z, Herchel R, Jewula P, Dvořák Z. A potential method to improve the in vitro cytotoxicity of half-sandwich Os(ii) complexes against A2780 cells. Dalton Trans 2018; 47:5714-5724. [DOI: 10.1039/c8dt00193f] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
[Os(η6-pcym)(dpa)(VP)]PF6 (1-VP), containing the histone deacetylase inhibitor valproate, shows ca. 3-fold higher in vitro cytotoxicity against the A2780 human ovarian carcinoma cells than its chlorido analogue [Os(η6-pcym)(dpa)Cl]PF6 (1-Cl).
Collapse
Affiliation(s)
- Pavel Štarha
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials
- Faculty of Science
- Palacký University in Olomouc
- 771 46 Olomouc
- Czech Republic
| | - Zdeněk Trávníček
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials
- Faculty of Science
- Palacký University in Olomouc
- 771 46 Olomouc
- Czech Republic
| | - Radovan Herchel
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials
- Faculty of Science
- Palacký University in Olomouc
- 771 46 Olomouc
- Czech Republic
| | - Pawel Jewula
- Department of Inorganic Chemistry & Regional Centre of Advanced Technologies and Materials
- Faculty of Science
- Palacký University in Olomouc
- 771 46 Olomouc
- Czech Republic
| | - Zdeněk Dvořák
- Department of Cell Biology and Genetics & Regional Centre of Advanced Technologies and Materials
- Faculty of Science
- Palacký University in Olomouc
- 783 71 Olomouc
- Czech Republic
| |
Collapse
|
14
|
Ocasio CA, Sansook S, Jones R, Roberts JM, Scott TG, Tsoureas N, Coxhead P, Guille M, Tizzard GJ, Coles SJ, Hochegger H, Bradner JE, Spencer J. Pojamide: An HDAC3-Selective Ferrocene Analogue with Remarkably Enhanced Redox-Triggered Ferrocenium Activity in Cells. Organometallics 2017. [DOI: 10.1021/acs.organomet.7b00437] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Affiliation(s)
- Cory A. Ocasio
- Genome
Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RQ, U.K
| | - Supojjanee Sansook
- Department
of Chemistry, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, U.K
| | - Rhiannon Jones
- Department
of Chemistry, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, U.K
| | - Justin M. Roberts
- Department
of Medical Oncology, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, Massachusetts 02215, United States
| | - Thomas G. Scott
- Department
of Medical Oncology, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, Massachusetts 02215, United States
| | - Nikolaos Tsoureas
- Department
of Chemistry, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, U.K
| | - Peter Coxhead
- School
of Biological Sciences, University of Portsmouth, King Henry Building, Portsmouth PO1 2DT, U.K
| | - Matthew Guille
- School
of Biological Sciences, University of Portsmouth, King Henry Building, Portsmouth PO1 2DT, U.K
| | - Graham J. Tizzard
- UK
National Crystallography Service, School of Chemistry, University of Southampton, Highfield Campus, Southampton SO17 1BJ, U.K
| | - Simon J. Coles
- UK
National Crystallography Service, School of Chemistry, University of Southampton, Highfield Campus, Southampton SO17 1BJ, U.K
| | - Helfrid Hochegger
- Genome
Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9RQ, U.K
| | - James E. Bradner
- Department
of Medical Oncology, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, Massachusetts 02215, United States
| | - John Spencer
- Department
of Chemistry, School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QJ, U.K
| |
Collapse
|